MedPath

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1.3k

Active:27
Completed:998

Trial Phases

6 Phases

Early Phase 1:17
Phase 1:106
Phase 2:103
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1070 trials with phase data)• Click on a phase to view related trials

Not Applicable
764 (71.4%)
Phase 1
106 (9.9%)
Phase 2
103 (9.6%)
Phase 4
65 (6.1%)
Early Phase 1
17 (1.6%)
Phase 3
15 (1.4%)

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

Not Applicable
Not yet recruiting
Conditions
Caregiver
Caregiver Distress
Caregiver to a Young Adult With Early Psychosis
Family Caregivers
First Posted Date
2025-11-06
Last Posted Date
2025-11-06
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
30
Registration Number
NCT07225179
Locations
🇺🇸

UNC Department of Psychiatry, Chapel Hill, North Carolina, United States

The DART DELIVER-02 Study

Not Applicable
Recruiting
Conditions
HIV (Human Immunodeficiency Virus)
Interventions
Other: Temporary treatment interruption
First Posted Date
2025-10-16
Last Posted Date
2025-10-16
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
24
Registration Number
NCT07217379
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

🇰🇪

Moi University Clinical Research Center, Eldoret, Kenya

🇰🇪

Kenya Medical Research Institute/Walter Reed Project, Kericho, Kenya

Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure

Not Applicable
Not yet recruiting
Conditions
Shoulder Surgery
Obesity
Interventions
Procedure: Ultrasound-Guided Interscalene Brachial Plexus Block
Procedure: Phrenic-Sparing Block Combination (Experimental)
First Posted Date
2025-10-15
Last Posted Date
2025-10-20
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
68
Registration Number
NCT07216820
Locations
🇺🇸

University of North Carolina Hospitals, Chapel Hill, North Carolina, United States

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Not Applicable
Recruiting
Conditions
Opioid Use
Surgical Recovery
Vaginal Hysterectomy
Prolapse Pelvic
Postoperative Pain
Interventions
Drug: Bupivacaine-epinephrine
Drug: Normal saline
First Posted Date
2025-10-09
Last Posted Date
2025-10-24
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
56
Registration Number
NCT07213635
Locations
🇺🇸

University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX, Raleigh, North Carolina, United States

REAL-Fam Feasibility Study for Youth Diabetes Management

Not Applicable
Not yet recruiting
Conditions
Type 1 Diabetes
First Posted Date
2025-10-08
Last Posted Date
2025-10-08
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
16
Registration Number
NCT07212790
Locations
🇺🇸

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 263
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.